MYLENE TRUONG to Neoplasms
This is a "connection" page, showing publications MYLENE TRUONG has written about Neoplasms.
Connection Strength
0.212
-
Differentiating pericardial recesses from mediastinal adenopathy: potential pitfalls in oncological imaging. Clin Radiol. 2014 Mar; 69(3):307-14.
Score: 0.072
-
Imaging spectrum of adverse events of immune checkpoint inhibitors. Clin Radiol. 2021 Apr; 76(4):262-272.
Score: 0.029
-
Abdominal and pelvic complications of nonoperative oncologic therapy. Radiographics. 2014 Jul-Aug; 34(4):941-61.
Score: 0.019
-
High prevalence of recurrent thrombosis in subsets of cancer patients with isolated gonadal vein thrombosis: a single center retrospective study. Thromb Res. 2014 Feb; 133(2):154-7.
Score: 0.018
-
Imaging of complications of oncological therapy in the gastrointestinal system. Cancer Imaging. 2012 May 07; 12:163-72.
Score: 0.016
-
The reversed halo sign: update and differential diagnosis. Br J Radiol. 2012 Sep; 85(1017):1226-35.
Score: 0.016
-
Clinical significance and epidemiologic analyses of Mycobacterium avium and Mycobacterium intracellulare among patients without AIDS. J Clin Microbiol. 2005 Sep; 43(9):4407-12.
Score: 0.010
-
Focal FDG uptake in mediastinal brown fat mimicking malignancy: a potential pitfall resolved on PET/CT. AJR Am J Roentgenol. 2004 Oct; 183(4):1127-32.
Score: 0.010
-
Clinical and pharmacokinetic study of TNP-470, an angiogenesis inhibitor, in combination with paclitaxel and carboplatin in patients with solid tumors. Cancer Chemother Pharmacol. 2004 Oct; 54(4):308-14.
Score: 0.009
-
Drug-induced Lung Disease in the Oncology Patient: From Cytotoxic Agents to Immunotherapy. Clin Chest Med. 2024 Jun; 45(2):325-337.
Score: 0.009
-
Phase I dose escalation and pharmacokinetic study of enzastaurin, an oral protein kinase C beta inhibitor, in patients with advanced cancer. J Clin Oncol. 2006 Sep 01; 24(25):4092-9.
Score: 0.003